Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (VIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,067,745
  • Shares Outstanding, K 130,612
  • Annual Sales, $ 76,370 K
  • Annual Income, $ -298,670 K
  • 60-Month Beta -1.32
  • Price/Sales 66.86
  • Price/Cash Flow N/A
  • Price/Book 6.89
Trade VIR with:

Options Overview Details

View History
  • Implied Volatility 77.05%
  • Historical Volatility 104.32%
  • IV Percentile 0%
  • IV Rank 0.54%
  • IV High 274.96% on 02/01/21
  • IV Low 75.98% on 09/09/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 1,970
  • Volume Avg (30-Day) 1,181
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 8,028
  • Open Int (30-Day) 10,530

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.73
  • Prior Year -0.67
  • Growth Rate Est. (year over year) +55.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.61 +22.94%
on 10/04/21
54.15 -25.96%
on 09/20/21
-14.45 (-26.49%)
since 09/17/21
3-Month
32.61 +22.94%
on 10/04/21
54.60 -26.58%
on 09/17/21
+1.38 (+3.56%)
since 07/19/21
52-Week
25.31 +58.40%
on 01/04/21
141.01 -71.57%
on 01/27/21
+3.50 (+9.57%)
since 10/19/20

Most Recent Stories

More News
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at AASLD’s The Liver Meeting® 2021

SAN FRANCISCO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting data from its...

VIR : 40.19 (+3.58%)
Vir Biotechnology to Participate in the H. C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical...

VIR : 40.19 (+3.58%)
AstraZeneca (AZN) Seeks Emergency Nod for COVID Prevention Drug

If authorized by the FDA, AstraZeneca's (AZN) AZD7442 would be the first long-acting cocktail antibody drug approved for COVID-19 prevention.

REGN : 551.67 (+1.51%)
AZN : 60.23 (+1.59%)
LLY : 241.66 (+1.12%)
VIR : 40.19 (+3.58%)
Pre-Market Brief: U.S. Stocks to Open Higher as Evergrande’s Debt Woes Ease

Morning Markets Dec S&P 500 futures this morning are up by +0.58%. U.S. stock index futures are moving higher this morning as concerns about China’s Evergrande Group’s debt woes eased after the company...

FCX : 38.71 (+0.44%)
CLF : 21.04 (-1.59%)
AA : 54.51 (-4.77%)
X : 21.91 (+0.27%)
SFIX : 33.50 (+0.63%)
RKLB : 12.37 (-0.24%)
MRIN : 7.43 (unch)
FDX : 230.09 (+0.93%)
ADBE : 636.63 (+2.22%)
VIR : 40.19 (+3.58%)
H : 85.63 (-0.31%)
Antibody drugs are no cure but seem promising for COVID-19

WASHINGTON (AP) — They’re not cures and it’s not likely that everyone will be able to get them as President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given...

LLY : 241.66 (+1.12%)
REGN : 551.67 (+1.51%)
VIR : 40.19 (+3.58%)
AMGN : 206.05 (+1.44%)
Companies test antibody drugs to treat, prevent COVID-19

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune...

REGN : 551.67 (+1.51%)
AMGN : 206.05 (+1.44%)
LLY : 241.66 (+1.12%)
VIR : 40.19 (+3.58%)
Live Nation, Carnival fall; Vir Biotechnology, rises

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Thursday:

CCL : 22.38 (-3.24%)
BA : 216.37 (-0.28%)
VIR : 40.19 (+3.58%)
LYV : 100.85 (-1.52%)
APA : 27.03 (+0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus...

See More

Key Turning Points

3rd Resistance Point 40.36
2nd Resistance Point 39.92
1st Resistance Point 39.36
Last Price 40.19
1st Support Level 38.35
2nd Support Level 37.91
3rd Support Level 37.35

See More

52-Week High 141.01
Fibonacci 61.8% 96.81
Fibonacci 50% 83.16
Fibonacci 38.2% 69.51
Last Price 40.19
52-Week Low 25.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar